Brief: Aytu Biopharma Announces Exclusive Deal With Medomie In Israel And Palestinian Authority
31/07/2023 13:17
July 31 (Reuters) - Aytu Biopharma Inc AYTU.O :
* AYTU BIOPHARMA: EXCLUSIVE DEAL WITH MEDOMIE PHARMA TO
COMMERCIALIZE ADZENYS XR-ODT AND COTEMPLA XR-ODT IN ISRAEL AND
PALESTINIAN AUTHORITY
* AYTU BIOPHARMA INC - MEDOMIE WILL SEEK LOCAL REGULATORY
APPROVALS AND MARKETING AUTHORIZATIONS FOR BOTH ADZENYS AND
COTEMPLA
Further company coverage: AYTU.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aytu Biopharma
See all newsAytu Biopharma Inc reports results for the quarter ended March 31 - Earnings Summary
Aytu BioPharma Q4 revenue beats analyst estimates on EXXUA sales
Aytu Biopharma Inc expected to post a loss of 32 cents a share - Earnings Preview
Aytu BioPharma Q3 revenue falls amid EXXUA launch
Aytu BioPharma Q2 revenue beats expectations